Fig. 7
From: Predicting survival times for neuroblastoma patients using RNA-seq expression profiles
Kaplan-Meier estimates for HR and LPS2. Kaplan-Meier estimates for overall survival (left column) and event-free survival (right column) of clinically high risk patients using the null model (first row) and the ensemble approach (second row). The orange line corresponds to patients labeled as LPS2 (predicted survival time less than 2 years), and blue lines are non-LPS2. The p-values are for the logrank test